PulmoVista 500 for monitoring ventilation in critical care (MIB203)
NICE has developed a medtech innovation briefing (MIB) on PulmoVista 500 for monitoring ventilation in critical care
NICE has developed a medtech innovation briefing (MIB) on PulmoVista 500 for monitoring ventilation in critical care
NICE has developed a medtech innovation briefing (MIB) on Spartan RX point-of-care CYP2C19 test to guide treatment in acute coronary syndrome
NICE has developed a medtech innovation briefing (MIB) on FebriDx for C-reactive protein and myxovirus resistance protein A testing
NICE has developed a medtech innovation briefing (MIB) on Helge for detecting haemolysis
NICE has developed a medtech innovation briefing (MIB) on Synergo for non-muscle-invasive bladder cancer
NICE has developed a medtech innovation briefing (MIB) on t:slim X2 insulin pump for managing blood glucose levels in type 1 diabetes
NICE has developed a medtech innovation briefing (MIB) on Novii Wireless Patch System for maternal and fetal monitoring
NICE has developed a medtech innovation briefing (MIB) on HemaClear for bloodless surgical field during limb surgery
NICE has developed a medtech innovation briefing (MIB) on Endo-SPONGE for colorectal anastomotic leakage
NICE has developed a medtech innovation briefing (MIB) on the V.A.C. Veraflo Therapy system for infected wounds
NICE has developed a medtech innovation briefing (MIB) on SuperNO2VA for the relief of upper airway obstruction in people with obstructive sleep apnoea
NICE has developed a medtech innovation briefing (MIB) on UroShield for preventing catheter-associated urinary infections
NICE has developed a medtech innovation briefing (MIB) on Actim Pancreatitis for diagnosing acute pancreatitis
NICE has developed a medtech innovation briefing (MIB) on CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic
NICE has developed a medtech innovation briefing (MIB) on Prontosan for acute and chronic wounds
NICE has developed a medtech innovation briefing (MIB) on Healthy.io test for home testing of urine albumin to creatinine ratio
NICE has developed a medtech innovation briefing (MIB) on pCONUS2 Bifurcation Aneurysm Implant for complex intracranial aneurysms
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing CT brain scans
NICE has developed a medtech innovation briefing (MIB) on NATROX oxygen wound therapy for managing diabetic foot ulcers and complex or chronic non-healing wound
NICE has developed a medtech innovation briefing (MIB) on EarlyCDT-Lung for cancer risk classification of indeterminate pulmonary nodules
NICE has developed a medtech innovation briefing (MIB) on Peezy Midstream for urine collection
NICE has developed a medtech innovation briefing (MIB) on DuraGraft for preserving vascular grafts
NICE has developed a medtech innovation briefing (MIB) on Danis stent for acute oesophageal variceal bleeds
NICE has developed a medtech innovation briefing (MIB) on the OPTIMIZER smart system for managing heart failure
NICE has developed a medtech innovation briefing (MIB) on Plus Sutures for preventing surgical site infection
NICE has developed a medtech innovation briefing (MIB) on National Early Warning Score systems that alert to deteriorating adult patients in hospital
NICE has developed a medtech innovation briefing (MIB) on Cor-Knot for tying suture knots in valve surgery
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence in mammography
NICE has developed a medtech innovation briefing (MIB) on Optilume for anterior urethral strictures
NICE has developed a medtech innovation briefing (MIB) on artificial intelligence for analysing chest CT images
NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility
Companies can now submit medicines for the new Innovative Licensing and Access Pathway (ILAP) following close collaboration between the NICE, drug regulators, the NHS and equivalent organisations in Scotland.
Final guidance from NICE recommends the PLASMA system
Following the successful evaluation of Zio XT, developers of digital health technologies are encouraged to engage with NICE through one of several different routes
NICE is taking part in the European Health Data and Evidence Network (EHDEN) project, which is exploring the use of common data models for healthcare research. This could support faster patient access to innovative medicines in areas of unmet need.
NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more data can be collected while patients can access the treatment.
Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.
NICE, the Royal College of General Practitioners (RCGP) and the Scottish Intercollegiate Guidelines Network (SIGN) have today (18 December 2020) published a guideline on the management of the long-term effects of COVID-19 (also known as Long COVID).
NICE, PHE and SACN have today published rapid guidance on vitamin D for COVID-19.
NICE is collaborating with the London School of Economics and Political Science (LSE) to develop an executive master’s degree in health care decision-making.
This advice has been updated and replaced by NICE medical technologies guidance 46.
This advice has been updated and replaced by NICE medical technologies guidance 44.
This advice has been updated and replaced by NICE diagnostics guidance 38.
This medtech innovation briefing has been updated and replaced by NICE diagnostics guidance 39.
We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.
This advice has been updated and replaced by NICE medical technologies guidance 43.
This medtech innovation briefing (MIB) has been updated and replaced by NICE diagnostics guidance 41.
This medtech innovation briefing has been updated and replaced by NICE medical technologies guidance 49.
This advice has been updated and replaced by NICE medical technologies guidance 50.
This advice has been updated and replaced by NICE medical technologies guidance 51.